Director, Product Management, Low Throughput NGS Systems at Illumina

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Genomics, BiotechnologyIndustries

Requirements

Deep genomic product and market expertise for both RUO and Dx system offerings
Strategic thinking and analytical excellence
Influential leadership to shape and manage complex, innovative product offerings
Experience across the RUO to Dx system continuum, including bringing Dx systems to market

Responsibilities

Leads a team assessing market opportunities, trends, customer needs, technology, and competitive landscape for MiSeq and LT NGS Systems across RUO and Dx, in partnership with customer/field marketing, commercial leadership, and sales teams
Develops strategic plan for investment and revenue growth in LT NGS systems, focused on targeted customer segments
Leads and manages product management team on product lifecycle activities, including new product proposals, development, product launch readiness, technical content for NPIs, product conversions, and EOL activities for library preparation and array product portfolio
Acts as primary interface with operations team to manage portfolio forecasting, inventory, back orders, and external communications on product issues to optimize global asset utilization
Drives lifecycle management activities to support revenue growth goals across markets and orchestrates EOL strategy to optimize revenue
Designs/implements effective forecasting models (quarterly, annual, 2-5 Year) with granularity at product family, market segment, and regional level, in partnership with stakeholders
Sets high-level pricing strategy in coordination with Pricing COE, including regional drivers
Sets and delivers against product revenue and profitability goals
Acts as internal and external evangelist shaping corporate and marketing strategy
Interfaces between operations and marketing/sales leadership
Provides input on product/service needs to R&D and technical platform roadmap
Partners with product marketing to provide guidance, input, and sign-off for GTM strategy and plans
Serves as single owner for NPI commercial success across commercial functions, primary point of contact for leadership, and accountable for year 1 NPI revenue
Develops content and communicates new product technical training with global segment marketing
Performs competitive differentiation and analysis of performance

Skills

Product Management

NGS

Genomics

Strategic Planning

Market Analysis

Business Planning

Competitive Analysis

RUO Systems

Dx Systems

Leadership

Product Lifecycle

Cross-functional Collaboration

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free